Namita Thapar likely to make Rs 127 Cr through Emcure Pharmaceuticals IPO

Namita Thapar, a promoter group member of Emcure Pharmaceuticals and known for her appearance on Shark Tank, is set to earn approximately Rs 127 crore through the company's upcoming IPO.

The issue, which opens on July 3 and closes on July 5, will see Thapar sell a portion of her stake, amounting to about 12.68 lakh shares, under the offer for sale (OFS) component.

According to a report, Thapar acquired her shares in Emcure at a weighted average price of Rs 3.44 per share.

With the upper price band of the IPO set at Rs 1,008, her stake sale is expected to generate around Rs 127 crore.

 As of March 2024, Thapar holds approximately 63 lakh shares, representing a 3.5% stake in the company.

The IPO consists of a fresh issuance of equity shares worth Rs 800 crore and an OFS of 1.14 crore equity shares by promoters and existing shareholders.

In addition to Thapar, promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity firm Bain Capital, will also be selling their stakes through the OFS.